Tag: bioequivalence

0

Latest FDA Bioequivalence Guidelines 2025: How the New Requirements Shape Your Generic Entry Strategy

The pharmaceutical landscape from 2025 onwards will undergo a structural shift driven by the latest FDA bioequivalence guidelines (2025). These guidelines are aimed at tightening study expectations while streamlining regulatory pathways for generics. For generic developers, this evolving BE framework is not just a compliance update. Rather, the new BE framework fundamentally impacts formulation strategy, […]

Read More →
0

Global Acceptance Of Bioavailability & Bioequivalence Studies: Key Regulatory Requirements By Country

Bioavailability (BA) and bioequivalence (BE) studies ensure that generic drugs provide the same therapeutic effect as their branded equivalents. Regulatory authorities worldwide validate the safety and efficacy of generic medicines through these studies before allowing them into their markets. However, the acceptance of BA/BE studies varies from country to country, with different criteria for approving […]

Read More →